Reduction of APOE accounts for neurobehavioral deficits in fetal alcohol spectrum disorders.
Saved in:
| Title: | Reduction of APOE accounts for neurobehavioral deficits in fetal alcohol spectrum disorders. |
|---|---|
| Authors: | Hwang HM; Center for Neuroscience Research, The Children's Research Institute, Children's National Hospital, Washington, DC, USA., Yamashita S; Center for Neuroscience Research, The Children's Research Institute, Children's National Hospital, Washington, DC, USA., Matsumoto Y; Center for Neuroscience Research, The Children's Research Institute, Children's National Hospital, Washington, DC, USA., Ito M; Center for Neuroscience Research, The Children's Research Institute, Children's National Hospital, Washington, DC, USA.; Department of Diabetes, Endocrinology and Metabolism, Tokyo Medical University, Tokyo, Japan., Edwards A; Center for Neuroscience Research, The Children's Research Institute, Children's National Hospital, Washington, DC, USA., Sasaki J; Center for Neuroscience Research, The Children's Research Institute, Children's National Hospital, Washington, DC, USA.; Department of Diabetes, Endocrinology and Metabolism, Tokyo Medical University, Tokyo, Japan., Dutta DJ; Center for Neuroscience Research, The Children's Research Institute, Children's National Hospital, Washington, DC, USA., Mohammad S; Center for Neuroscience Research, The Children's Research Institute, Children's National Hospital, Washington, DC, USA., Yamashita C; Center for Neuroscience Research, The Children's Research Institute, Children's National Hospital, Washington, DC, USA., Wetherill L; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA., Schwantes-An TH; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA., Abreu M; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA., Mahnke AH; Department of Neuroscience and Experimental Therapeutics, Texas A&M University School of Medicine, Bryan, TX, USA., Mattson SN; Center for Behavioral Teratology, San Diego State University, San Diego, CA, USA., Foroud T; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA., Miranda RC; Department of Neuroscience and Experimental Therapeutics, Texas A&M University School of Medicine, Bryan, TX, USA., Chambers C; Department of Pediatrics, University of California San Diego, San Diego, CA, USA., Torii M; Center for Neuroscience Research, The Children's Research Institute, Children's National Hospital, Washington, DC, USA. mtorii@childrensnational.org.; Departments of Pediatrics, and Pharmacology & Physiology, School of Medicine and Health Sciences, The George Washington University, Washington, DC, USA. mtorii@childrensnational.org., Hashimoto-Torii K; Center for Neuroscience Research, The Children's Research Institute, Children's National Hospital, Washington, DC, USA. khtorii@childrensnational.org.; Departments of Pediatrics, and Pharmacology & Physiology, School of Medicine and Health Sciences, The George Washington University, Washington, DC, USA. khtorii@childrensnational.org. |
| Source: | Molecular psychiatry [Mol Psychiatry] 2024 Nov; Vol. 29 (11), pp. 3364-3380. Date of Electronic Publication: 2024 May 11. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Group Specialist Journals Country of Publication: England NLM ID: 9607835 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5578 (Electronic) Linking ISSN: 13594184 NLM ISO Abbreviation: Mol Psychiatry Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
